[为了优化老年人AML治疗]
1Department of Hematology, Japanese Red Cross Musashino Hospital.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 2, 2024
概括
针对急性髓性白血病 (AML) 的强化化疗可能对老年患者来说过于有毒. 一个新的基于并发症的风险系统有助于量身定制治疗强度,以获得更好的AML结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床治疗学 临床治疗学
背景情况:
- 传统的急性髓性白血病 (AML) 治疗包括密集化疗和移植,旨在缓解和治愈.
- 然而,密集化疗带来了显著的毒性风险,特别是对于老年患者和患有并发症的患者.
- 低强度化疗选择,包括甲基化抑制剂和venetoclax,为这些患者群体提供了有前途的替代方案.
研究的目的:
- 评估年龄和伴随性疾病在AML治疗选择中的作用.
- 引入和评估AML的基于并发症的风险分层系统.
- 优化治疗强度,以提高AML患者的疗效和安全性.
主要方法:
- 审查传统和新兴的AML治疗策略.
- 对拟议的基于并发症的风险分层系统的分析.
- 基于风险分层的治疗强度优化的评估.
主要成果:
- 在老年人和并发性AML患者中,强化化疗的益处可能会被毒性所抵消.
- 低强度化疗 (例如甲基化抑制剂,venetoclax) 对特定患者群体有希望.
- 基于并发症的风险分层系统适用于强化和低强度化疗方案.
结论:
- 对AML的治疗选择必须越来越多地考虑患者的年龄和并发症.
- 风险分层系统对于个性化AML治疗强度至关重要.
- 根据风险分层优化治疗强度可以提高AML治疗的疗效,安全性和预后.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.2K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Bone Marrow Sampling and Transplants
313
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
313
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
